UN Foundation gets $139M measles initiative donation

5 March 2007

The United Nations Foundation has received a $139.0 million contribution from the GAVI Alliance to support the former's efforts to reduce measles deaths worldwide 90% by 2010. The Measles Initiative is a public-private partnership between the American Red Cross, the US Centers for Disease Control and Prevention (CDC), the UN Foundation, UNICEF and the World Health Organization. The initiative aims to cut deaths from measles worldwide by this amount, having seen a 60% reduction from 1999 to 2005.

The GAVI Alliance's donation was made possible by the recent creation of the International Finance Facility for Immunization (IFFIm; Marketletters passim). Alan Gillespie, chairman of the IFFIm board, said: "the IFFIm was designed to accelerate availability of resources for priority vaccination programs. The Measles Initiative presents a particularly strong case for this significant investment."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight